MedPath

山西新星制药有限公司

Ownership
-
Established
2004-05-14
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

34

NMPA:34

Drug Approvals

Vitamin U,Belladonna and Aluminium CapsulesⅢ

Product Name
维U颠茄铝胶囊(Ⅲ)
Approval Number
国药准字H14023069
Approval Date
May 25, 2021
NMPA

Erythromycin Enteric-coated Tablets

Product Name
红霉素肠溶片
Approval Number
国药准字H14020095
Approval Date
Aug 28, 2020
NMPA

Rutin Tablets

Product Name
芦丁片
Approval Number
国药准字H14020096
Approval Date
Aug 28, 2020
NMPA

Paracetamol,Caffeine,Artificial Cow-bezoar and Chlorphenamine Maleate Capsules

Product Name
氨咖黄敏胶囊
Approval Number
国药准字H14023063
Approval Date
Aug 28, 2020
NMPA

Vitamin B1 Tablets

Product Name
维生素B1片
Approval Number
国药准字H14020102
Approval Date
Aug 28, 2020
NMPA

lsoniazid Tablets

Product Name
异烟肼片
Approval Number
国药准字H14020105
Approval Date
Aug 28, 2020
NMPA

Tetracycline Tablets

Product Name
四环素片
Approval Number
国药准字H14020100
Approval Date
Aug 28, 2020
NMPA

Compound Diclofenac Sodium and Chlorphenamine Maleate Tablets

Product Name
氯芬黄敏片
Approval Number
国药准字H14023066
Approval Date
Aug 28, 2020
NMPA

Furazolidone Tablets

Product Name
呋喃唑酮片
Approval Number
国药准字H14020343
Approval Date
Aug 28, 2020
NMPA

Oyster Shell Calcium Capsules

Product Name
牡蛎碳酸钙胶囊
Approval Number
国药准字H14023067
Approval Date
Aug 28, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.